{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T14:00:56Z","timestamp":1784210456919,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Japanese Foundation for Multidisciplinary Treatment of Cancer"},{"name":"Gastrointestinal Cancer Project funded by Nakayama Cancer Research Institute"},{"name":"Japan Society for the Promotion of Science (JSPS) KAKENHI","award":["18K16338"],"award-info":[{"award-number":["18K16338"]}]},{"name":"Japan Society for the Promotion of Science (JSPS) KAKENHI","award":["19K09209"],"award-info":[{"award-number":["19K09209"]}]},{"name":"Public Trust Fund for Clinical Cancer Research"},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1245\/s10434-021-10997-w","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T14:03:07Z","timestamp":1636120987000},"page":"2685-2697","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Impact of Tumor-Derived DNA Testing in Peritoneal Lavage of Pancreatic Cancer Patients with and Without Occult Intra-Abdominal Metastases"],"prefix":"10.1245","volume":"29","author":[{"given":"Kazuharu","family":"Chiba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5155-2508","authenticated-orcid":false,"given":"Tatsuo","family":"Hata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamichi","family":"Mizuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuyuki","family":"Takadate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyuhiko","family":"Motoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Unno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,5]]},"reference":[{"key":"10997_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7\u201330.","journal-title":"CA Cancer J Clin."},{"key":"10997_CR2","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1056\/NEJMra1404198","volume":"371","author":"DP Ryan","year":"2014","unstructured":"Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. N Engl J Med. 2014;371:1039\u201349.","journal-title":"N Engl J Med."},{"key":"10997_CR3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41575-018-0005-x","volume":"15","author":"JP Neoptolemos","year":"2018","unstructured":"Neoptolemos JP, Kleeff J, Michl P, et al. Therapeutic developments in pancreatic cancer: current and future perspectives. Nat Rev Gastroenterol Hepatol. 2018;15:333\u201348.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"10997_CR4","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1002\/bjs.1800820839","volume":"82","author":"C Fernandez-del Castillo","year":"1995","unstructured":"Fernandez-del Castillo C, Rattner DW, Warshaw AL. Further experience with laparoscopy and peritoneal cytology in the staging of pancreatic cancer. Br J Surg. 1995;82:1127\u20139.","journal-title":"Br J Surg."},{"key":"10997_CR5","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1007\/s11605-018-3726-9","volume":"22","author":"GA Looijen","year":"2018","unstructured":"Looijen GA, Pranger BK, de Jong KP, et al. The Additional Value of Laparoscopic Ultrasound to Staging Laparoscopy in Patients with Suspected Pancreatic Head Cancer. J Gastrointest Surg. 2018;22:1186\u201392.","journal-title":"J Gastrointest Surg."},{"key":"10997_CR6","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1245\/s10434-017-6317-1","volume":"25","author":"NM Sell","year":"2018","unstructured":"Sell NM, Fong ZV, Del Castillo CF, et al. Staging Laparoscopy Not Only Saves Patients an Incision, But May Also Help Them Live Longer. Ann Surg Oncol. 2018;25:1009\u201316.","journal-title":"Ann Surg Oncol."},{"key":"10997_CR7","first-page":"CD009323","volume":"7","author":"VB Allen","year":"2016","unstructured":"Allen VB, Gurusamy KS, Takwoingi Y, et al. Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer. Cochrane Database Syst Rev. 2016;7:CD009323.","journal-title":"Cochrane Database Syst Rev."},{"key":"10997_CR8","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.surg.2019.06.023","volume":"166","author":"H Tsuchida","year":"2019","unstructured":"Tsuchida H, Fujii T, Mizuma M, et al. Prognostic importance of peritoneal washing cytology in patients with otherwise resectable pancreatic ductal adenocarcinoma who underwent pancreatectomy: A nationwide, cancer registry-based study from the Japan Pancreas Society. Surgery. 2019;166:997\u20131003.","journal-title":"Surgery."},{"key":"10997_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11605-014-2637-7","volume":"19","author":"S Satoi","year":"2015","unstructured":"Satoi S, Murakami Y, Motoi F, et al. Reappraisal of peritoneal washing cytology in 984 patients with pancreatic ductal adenocarcinoma who underwent margin-negative resection. J Gastrointest Surg. 2015;19:6\u201314.","journal-title":"J Gastrointest Surg."},{"key":"10997_CR10","doi-asserted-by":"publisher","first-page":"15004","DOI":"10.18632\/oncotarget.14745","volume":"8","author":"F Cao","year":"2017","unstructured":"Cao F, Li J, Li A, et al. Prognostic significance of positive peritoneal cytology in resectable pancreatic cancer: a systemic review and meta-analysis. Oncotarget. 2017;8:15004\u201313.","journal-title":"Oncotarget."},{"key":"10997_CR11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.6004\/jnccn.2019.0014","volume":"17","author":"MA Tempero","year":"2019","unstructured":"Tempero MA, Malafa MP, Chiorean EG, et al. Pancreatic Adenocarcinoma, Version 1.2019. J Natl Compr Canc Netw. 2019;17:202\u201310.","journal-title":"J Natl Compr Canc Netw."},{"key":"10997_CR12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2012.45.2011","volume":"32","author":"LA Diaz Jr","year":"2014","unstructured":"Diaz LA Jr, Bardelli A. Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol. 2014;32:579\u201386.","journal-title":"J Clin Oncol."},{"key":"10997_CR13","doi-asserted-by":"publisher","first-page":"18425","DOI":"10.1038\/srep18425","volume":"5","author":"E Takai","year":"2015","unstructured":"Takai E, Totoki Y, Nakamura H, et al. Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer. Sci Rep. 2015;5:18425.","journal-title":"Sci Rep."},{"key":"10997_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1126\/scitranslmed.3007094","volume":"6","author":"C Bettegowda","year":"2014","unstructured":"Bettegowda C, Sausen M, Leary RJ, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014;6:224.","journal-title":"Sci Transl Med."},{"key":"10997_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12885-018-5195-7","volume":"19","author":"MH Choi","year":"2019","unstructured":"Choi MH, Mejlaender-Andersen E, Manueldas S, et al. Mutation analysis by deep sequencing of pancreatic juice from patients with pancreatic ductal adenocarcinoma. BMC Cancer. 2019;19:11.","journal-title":"BMC Cancer."},{"key":"10997_CR16","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.pan.2016.01.007","volume":"16","author":"T Hata","year":"2016","unstructured":"Hata T, Ishida M, Motoi F, et al. Telomerase activity in pancreatic juice differentiates pancreatic cancer from chronic pancreatitis: A meta-analysis. Pancreatology. 2016;16:372\u201381.","journal-title":"Pancreatology."},{"key":"10997_CR17","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1158\/1078-0432.CCR-17-2463","volume":"24","author":"M Suenaga","year":"2018","unstructured":"Suenaga M, Yu J, Shindo K, et al. Pancreatic Juice Mutation Concentrations Can Help Predict the Grade of Dysplasia in Patients Undergoing Pancreatic Surveillance. Clin Cancer Res. 2018;24:2963\u201374.","journal-title":"Clin Cancer Res."},{"key":"10997_CR18","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1002\/cncr.26558","volume":"118","author":"JB Kisiel","year":"2012","unstructured":"Kisiel JB, Yab TC, Taylor WR, et al. Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates. Cancer. 2012;118:2623\u201331.","journal-title":"Cancer."},{"key":"10997_CR19","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1158\/1078-0432.CCR-14-2467","volume":"21","author":"TP Radon","year":"2015","unstructured":"Radon TP, Massat NJ, Jones R, et al. Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma. Clin Cancer Res. 2015;21:3512\u201321.","journal-title":"Clin Cancer Res."},{"key":"10997_CR20","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1080\/15384047.2019.1638685","volume":"20","author":"H Terasawa","year":"2019","unstructured":"Terasawa H, Kinugasa H, Ako S, et al. Utility of liquid biopsy using urine in patients with pancreatic ductal adenocarcinoma. Cancer Biol Ther. 2019;20:1348\u201353.","journal-title":"Cancer Biol Ther."},{"key":"10997_CR21","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrclinonc.2017.14","volume":"14","author":"G Siravegna","year":"2017","unstructured":"Siravegna G, Marsoni S, Siena S, et al. Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol. 2017;14:531\u201348.","journal-title":"Nat Rev Clin Oncol."},{"key":"10997_CR22","doi-asserted-by":"publisher","first-page":"17761","DOI":"10.1038\/s41598-020-74868-2","volume":"10","author":"T Hata","year":"2020","unstructured":"Hata T, Mizuma M, Motoi F, et al. GNAS mutation detection in circulating cell-free DNA is a specific predictor for intraductal papillary mucinous neoplasms of the pancreas, especially for intestinal subtype. Sci Rep. 2020;10:17761.","journal-title":"Sci Rep."},{"key":"10997_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey P, Chang DK, Nones K, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016;531:47\u201352.","journal-title":"Nature."},{"key":"10997_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ccell.2017.07.007","volume":"32","author":"Cancer Genome Atlas Research Network","year":"2017","unstructured":"Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell. 2017;32:185\u2013203.","journal-title":"Cancer Cell."},{"key":"10997_CR25","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.surg.2018.06.047","volume":"164","author":"H Takahashi","year":"2018","unstructured":"Takahashi H, Akita H, Wada H, et al. Subclinical cancer cell dissemination in peritoneal lavage fluid detected by reverse-transcription polymerase chain reaction identifies patients at high risk for peritoneal recurrence and consequent impaired survival in the setting of preoperative chemoradiation therapy for pancreatic cancer. Surgery. 2018;164:1168\u201377.","journal-title":"Surgery."},{"key":"10997_CR26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jss.2017.11.009","volume":"226","author":"K Sato","year":"2018","unstructured":"Sato K, Mori R, Hiroshima Y, et al. RT-PCR of peritoneal washings predicts peritoneal pancreatic cancer recurrence. J Surg Res. 2018;226:122\u201330.","journal-title":"J Surg Res."},{"key":"10997_CR27","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1245\/s10434-009-0683-2","volume":"16","author":"KJ Kelly","year":"2009","unstructured":"Kelly KJ, Wong J, Gladdy R, et al. Prognostic impact of RT-PCR-based detection of peritoneal micrometastases in patients with pancreatic cancer undergoing curative resection. Ann Surg Oncol. 2009;16:3333\u20139.","journal-title":"Ann Surg Oncol."},{"key":"10997_CR28","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrc2375","volume":"8","author":"K Pantel","year":"2008","unstructured":"Pantel K, Brakenhoff RH, Brandt B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer. 2008;8:329\u201340.","journal-title":"Nat Rev Cancer."},{"key":"10997_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/00006676-200401000-00002","volume":"28","author":"Y Wang","year":"2004","unstructured":"Wang Y, Yamaguchi Y, Watanabe H, et al. Detection of p53 gene mutations in the supernatant of pancreatic juice and plasma from patients with pancreatic carcinomas. Pancreas. 2004;28:13\u20139.","journal-title":"Pancreas."},{"key":"10997_CR30","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/00006676-200111000-00004","volume":"23","author":"A Ha","year":"2001","unstructured":"Ha A, Watanabe H, Yamaguchi Y, et al. Usefulness of supernatant of pancreatic juice for genetic analysis of K-ras in diagnosis of pancreatic carcinoma. Pancreas. 2001;23:356\u201363.","journal-title":"Pancreas."},{"key":"10997_CR31","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1349-7006.1999.tb00739.x","volume":"90","author":"K Yamashita","year":"1999","unstructured":"Yamashita K, Kida Y, Shinoda H, et al. K-ras point mutations in the supernatants of pancreatic juice and bile are reliable for diagnosis of pancreas and biliary tract carcinomas complementary to cytologic examination. Jpn J Cancer Res. 1999;90:240\u20138.","journal-title":"Jpn J Cancer Res."},{"key":"10997_CR32","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.1158\/0008-5472.CAN-12-2217","volume":"72","author":"C Swanton","year":"2012","unstructured":"Swanton C. Intratumor heterogeneity: evolution through space and time. Cancer Res. 2012;72:4875\u201382.","journal-title":"Cancer Res."},{"key":"10997_CR33","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/SLA.0000000000001705","volume":"265","author":"S Satoi","year":"2017","unstructured":"Satoi S, Fujii T, Yanagimoto H, et al. Multicenter phase II study of intravenous and intraperitoneal paclitaxel with S-1 for pancreatic ductal adenocarcinoma patients with peritoneal metastasis. Ann Surg. 2017;265:397\u2013401.","journal-title":"Ann Surg."},{"issue":"13","key":"10997_CR34","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1002\/bjs.11792","volume":"107","author":"S Yamada","year":"2020","unstructured":"Yamada S, Fujii T, Yamamoto T, et al. Phase I\/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis. Br J Surg. 2020;107(13):1811\u20137.","journal-title":"Br J Surg."},{"key":"10997_CR35","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/nature09515","volume":"467","author":"S Yachida","year":"2010","unstructured":"Yachida S, Jones S, Bozic I, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature. 2010;467:1114\u20137.","journal-title":"Nature."},{"key":"10997_CR36","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1158\/2159-8290.CD-15-0120","volume":"5","author":"R Maddipati","year":"2015","unstructured":"Maddipati R, Stanger BZ. Pancreatic cancer metastases harbor evidence of polyclonality. Cancer Discov. 2015;5:1086\u201397.","journal-title":"Cancer Discov."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10997-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-10997-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10997-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T13:06:18Z","timestamp":1647608778000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-10997-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,5]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10997"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-10997-w","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,5]]},"assertion":[{"value":"2 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Michiaki Unno: Takeda Pharmaceuticals, Taiho Pharmaceuticals. Kazuharu Chiba, Tatsuo Hata, Masamichi Mizuma, Kunihiro Masuda, Shuichi Aoki, Tatsuyuki Takadate, Kei Kawaguchi, Kei Nakagawa, Takanori Morikawa, Fuyuhiko Motoi, and Toru Furukawa have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}